
view our CenterWatch profile
River Birch Research Alliance, LLC has been in operation for the past 15 years, and during this span we have worked on studies sponsored by many leading pharmaceutical companies and clinical research organizations (CROs).
Here is a brief list of studies our site has been selected for in past and the therapeutic areas and indications they cover:
| Indication | Sponsor | Year Started |
|---|---|---|
| Hypertension | Merck | 1994 |
| COPD | SmithKline | 1997 |
| Chronic Bronchitis | Bristol-Myers | 1999 |
| Irritable Bowel Syndrome | Glaxo Wellcome | 2000 |
| Pneumonia | Bayer | 2000 |
| Skin Infection | Eli Lilly | 2001 |
| Asthma | Aventis | 2002 |
| Type II Diabetes | AstraZeneca | 2002 |
| Migraine Headache | Pfizer | 2003 |
| COPD | ALTANA Pharma | 2003 |
| Gout | Pfizer | 2004 |
| Osteoporosis | Eli Lilly | 2004 |
| Osteoarthritis | Johnson & Johnson | 2005 |
| Type II Diabetes | Roche | 2005 |
| Atrial Fibrillation | Sanofi-Aventis | 2006 |
To obtain a complete list of all the studies we have participated in and the sponsors we have worked with, please click here.
We at River Birch Research Alliance, LLC are proud to continue our longstanding collaboration with our many sponsors, and are open to site recruitment and initiation year round. We also welcome new sponsors and CROs to contact us and establish a growing collaboration with our group.
To recruit our site, please contact:
Dr. Maxwell C. Eblaghie, PhD
Chief Research Officer
River Birch Research Alliance, LLC
101 Riverstone Vista, Suite 201B
Blue Ridge, GA 30513
phone: (706) 258-4112
fax: (706) 632-6006
email: